Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep397 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Correlation of obesity with diminished neutralizing antibody count

Nutsubidze Teona , Uchava Lasha , Giorgadze Elen

The obesity epidemic, which has persisted for more than 45 years, is now being faced concurrently with the coronavirus pandemic, with deadly effects. The complex changes caused by obesity, such as chronic inflammation, are known to be detrimental in patients with COVID-19. 33.2% of the Georgian population is obese (1). Therefore, we aimed to explore the synergistic effects between obesity and SARS-CoV-2. The objective of our study is to compare the presence of neutralizing ant...

ea0020p56 | Thyroid | ECE2009

Severe obesity accompanied with subclinical hypothyroidism

Asatiani Ketevan , Janjgava Shota , Uchava Lasha , Tsagareli Marina , Tsagareli Nana

Obesity is the modern medical problem. According to the WHO expert panel the prevalence of obese population worldwide is 300 million and overweight is 750 million.In the first trimester of 2007, we studied the obese patients in the Iv. Javakhishvili State Medical University’s Department of Endocrinology. The objective of our research was to study the course of subclinical hypothyroidism adjunct with severe obesity, its diagnostic criteria and treatm...

ea0020p513 | Endocrine Disruptors | ECE2009

Hyperprolactinaemia in men

Giorgadze Elen , Janjgava Shota , Lomidze Marina , Bakchtadze Tamta , Nozadze Natia , Uchava lasha , Svani Nino

The hyperprolactinemic disorder is a syndrome of prolactin hypersecretion. The syndrome is more prevalent in women than in men, but lately accidence of the syndrome disease tends to increase in men. Hyperprolactinemic disorder mostly affects men at the age range 40–59 years. Patients at the physician’s consultation have following complaints: erectile dysfunction, infertility, libido reduction, rarely gynecomastia.Sixteen patients were examined ...